Schrodinger Inc. (SDGR) shares plummeted 5.17% in Friday's intraday trading session, following the company's disappointing full-year 2024 earnings report. The healthcare technology company reported a net loss of $187.1 million, or a loss of $2.58 per share, for the fiscal year ended December 31, 2024. This marks a significant decline from the previous year when Schrodinger reported a profit of $40.7 million, or $0.57 per share.
While Schrodinger's revenue for FY2024 reached $207.5 million, beating analyst estimates by 2.6%, the reported earnings per share missed expectations by 6.9%. The company's revenue also decreased by 4.2% compared to the previous year, reflecting the challenges faced in the healthcare services industry.
Investors reacted negatively to the earnings miss, sending Schrodinger's stock price tumbling in Friday's trading session. The company's shares were already down 7.3% from a week ago, indicating growing concerns about its financial performance. As a result, the stock experienced a significant plummet, reflecting the market's disappointment with Schrodinger's FY2024 results.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。